Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality patient
care. It is applicable to specialists, primary care, and providers at all levels. is Guideline
should not be considered exclusive of other methods of care reasonably directed at obtaining the
same results. e ultimate judgment concerning the propriety of any course of conduct must be
made by the clinician aer consideration of each individual patient situation. Neither IGC,
the medical associations, nor the authors endorse any product or service associated with the
distributor of this clinical reference tool.
Source
Galgiani JN et al. 2016 Infectious Diseases Society of America (IDSA) Clinical
Practice Guideline for the Treatment of Coccidioidomycosis. Available at: http://cid.
oxfordjournals.org/content/early/2016/07/06/cid.ciw360.full.pdf+html. Accessed
August 2, 2016.
Abbreviations
AmB, amphotericin B; CAP, community-acquired pneumonia; CM, coccidioidal
meningitis; CNS, central nervous system; EIA, enzyme immunoassay; HSCT,
hematopoietic stem cell transplantation; ICP, intracranial pressure; IDCF, immunodiffusion
complement-fixing (anticoccidioidal antibodies); IgG, immunoglobulin G; IgM,
immunoglobulin M; MRI, magnetic resonance imaging ; VATS, video-assisted
thoracoscopic surgery
106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
For additional copies, order at GuidelineCentral.com
Copyright © 2016 All rights reserved
IDSACOC16083
